Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists have?
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists has 110 citations in the OpenAlex counts ScholarIQ stores.
When was Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists published?
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists has 2021 year in the ScholarIQ index.
What is the open-access status of Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists?
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists has hybrid oa status in the ScholarIQ index.
What is the DOI of Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists?
The DOI for Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists is on the source record.
What is the PMID of Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists?
The PMID for Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists is on the source record.
What is the OpenAlex record for Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists?
The OpenAlex for Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists is on the source record.